Teradan Clinical Trials | Brandon, FL

Research site

(Unclaimed)

Location

910 Oakfield Drive, Brandon, Florida, United States of America

Site insights

Top conditions

Top treatments

LY3437943

Retatrutide

Acetazolamide

Maridebart Cafraglutide

Atomoxetine

STI-2020

Ruxolitinib

Atomoxetine Hydrochloride

SUVN-G3031

R-oxybutynin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 23 total trials

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Active, not recruiting

Overweight

Obesity

Drug: Placebo

Drug: Retatrutide

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine

DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

The goal of this randomized, double-blind, multi-dose crossover clinical trial is to determine the safety and efficacy of IHL-42X in subjects with ob...

Not yet enrolling

Obstructive Sleep Apnea (OSA)

Drug: Placebo: Negative control

Drug: IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamide

Locations recently updated

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy (MARITIME-OSA-2)

This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in a...

Enrolling

Obstructive Sleep Apnea

Drug: Placebo

Drug: Maridebart cafraglutide

Locations recently updated

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy (MARITIME-OSA-1)

This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in a...

Enrolling

Obesity

Obstructive Sleep Apnea

Drug: Placebo

Drug: Maridebart cafraglutide

Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a centra...

Active, not recruiting

Sleep Apnea

Drug: SASS-001

Drug: Placebo